Fmr Llc

13F Holdings History for Denali Therapeutics Inc. - COMMON STOCK (DNLI)

Symbol: DNLI on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Ownership: 8.54M shares
Security Ownership: 5.8%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Denali Therapeutics Inc. COMMON STOCK (DNLI)

2025-11-05 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.54M shares of Denali Therapeutics Inc. COMMON STOCK (DNLI). This represents 5.8% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	5.8%		$124M	8.54M			$14.52	13G/A	9/30/2025	5 Nov 2025 11:30:18

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	0%	$92.1M	6.34M	-1,198,152	-15.9%	$14.52	Q3 2025
6/30/2025	0.01%	+0%	$105M	7.54M	+125,114	+1.69%	$13.99	Q2 2025
3/31/2025	0.01%	0%	$101M	7.41M	-606,392		$13.60	Q1 2025
12/31/2024	0.01%	+0%	$163M	8.02M	+188,368	+2.41%	$20.38	Q4 2024
9/30/2024	0.01%	+0.01%	$228M	7.83M	+7,596,508	+3234%	$29.13	Q3 2024
6/30/2024	0%	0%	$5.45M	235K	-997,652	-80.9%	$23.22	Q2 2024
3/31/2024	0%	+0%	$25.3M	1.23M	+590,869	+92.1%	$20.52	Q1 2024
12/31/2023	0%	0%	$13.8M	642K	-416,844	-39.4%	$21.46	Q4 2023
9/30/2023	0%	0%	$21.8M	1.06M	-21,360	-1.98%	$20.63	Q3 2023
6/30/2023	0%	0%	$31.9M	1.08M	-13,707	-1.25%	$29.51	Q2 2023
3/31/2023	0%	0%	$25.2M	1.09M	-1,120,230	-50.6%	$23.04	Q1 2023
12/31/2022	0.01%	0%	$61.6M	2.21M	-238,662	-9.73%	$27.81	Q4 2022
9/30/2022	0.01%	0%	$75.3M	2.45M	-417,284	-14.5%	$30.69	Q3 2022
6/30/2022	0.01%	0%	$84.5M	2.87M	-74,315	-2.52%	$29.43	Q2 2022
3/31/2022	0.01%	0%	$94.7M	2.94M	-7,736	-0.26%	$32.17	Q1 2022
12/31/2021	0.01%	+0%	$132M	2.95M	+276,042	+10.3%	$44.60	Q4 2021
9/30/2021	0.01%	+0%	$135M	2.68M	+6,666	+0.25%	$50.45	Q3 2021
6/30/2021	0.02%	0%	$209M	2.67M	-18,617	-0.69%	$78.44	Q2 2021
3/31/2021	0.01%	0%	$153M	2.69M	-826,509	-23.5%	$57.10	Q1 2021
12/31/2020	0.03%	-0.01%	$294M	3.51M	-1,357,259	-27.9%	$83.76	Q4 2020
9/30/2020	0.02%	+0%	$175M	4.87M	+57,353	+1.19%	$35.83	Q3 2020
6/30/2020	0.01%	0%	$116M	4.81M	-411,555	-7.88%	$24.18	Q2 2020
3/31/2020	0.01%	+0%	$91.5M	5.23M	+1,107,036	+26.9%	$17.51	Q1 2020
12/31/2019	0.01%	0%	$71.7M	4.12M	-791,363	-16.1%	$17.42	Q4 2019
9/30/2019	0.01%	0%	$75.2M	4.91M	-137,624	-2.73%	$15.32	Q3 2019
6/30/2019	0.01%	0%	$105M	5.05M	-443,489	-8.08%	$20.76	Q2 2019
3/31/2019	0.02%	0%	$128M	5.49M	-79,229	-1.42%	$23.22	Q1 2019
12/31/2018	0.02%	-0.01%	$115M	5.57M	-2,140,710	-27.8%	$20.66	Q4 2018
9/30/2018	0.02%	0%	$168M	7.71M	-325,977	-4.06%	$21.74	Q3 2018
6/30/2018	0.01%	0%	$123M	8.04M	-1,498,395	-15.7%	$15.25	Q2 2018
3/31/2018	0.02%	+0%	$188M	9.54M	+190,965	+2.04%	$19.69	Q1 2018
12/31/2017	0.02%	+0.02%	$146M	9.34M	+9,344,456	NEW	$15.64	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.